Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Tripeptides – e.g. – tripeptide thyroliberin – etc.
Patent
1995-06-05
1999-08-10
Tsang, Cecilia J.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Tripeptides, e.g., tripeptide thyroliberin , etc.
530330, 514 17, 514 18, 514 19, C07K 508
Patent
active
059360658
ABSTRACT:
The present invention contemplates a compound defined by the following formula: ##STR1## that inhibits the binding between the VLA-4 and the fibronectin CS-1 compound. Pharmaceutical compositions containing a contemplated compound and methods for treating immunoinflammatory conditions using the compound are also disclosed.
REFERENCES:
patent: 4822606 (1989-04-01), Snyderman et al.
patent: 5294511 (1994-03-01), Furcht et al.
patent: 5387504 (1995-02-01), Mumford
Ioria, et al., J. Med. Chem. 34:2615-2623 (1991).
Komoriya, Akira et al., "The Minimal Essential Sequence for a Major Cell Type-Specific Adhesion Site (CS1) Within the Alternatively Splice Type III Connecting Segment Domain of Fibronectin is Leucine-Aspartic Acid-Valine." J. Biol. Chem. 266:15075-15079 (1991).
Elices, Mariano "The Integrin .alpha..sub.r .beta..sub.1 (VLA-4) as a Therapeutic Target." Cell Adhesion and Human Disease. Wiley, Chichester (Ciba Foundation Symposium 189) pp. 79-90 (1995).
Nowlin, Dawn M., "A Novel Cyclic Pentapeptide Inhibits .alpha.4.beta.1 and .alpha.5.beta.1 Integrin-mediated Cell Adhesion." J. Biol. Chem. 268:20352-20359 (1993).
Mousa, Skaer A. et al., "Antiplatelet Efficacy and Specificity of DMP728, a Novel Platelet GP11B/IIIa Receptor Antagonist." Clin. Pharm. 83:373-382 (1993).
Pfaff, Martin et al., "Seletive Recognition of Cyclic RGD Peptides of NMR Defined Conformation by .alpha.V.beta.3, .alpha.5.beta.1 Integrins." J. Biol. Chem. 269:20233-20238 (1994).
Arrhenius Thomas S.
Elices Mariano J.
Gaeta Federico C. A.
Cytel Corporation
Lukton David
Tsang Cecilia J.
LandOfFree
CS-1 peptidomimetics, compositions and methods of using the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CS-1 peptidomimetics, compositions and methods of using the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CS-1 peptidomimetics, compositions and methods of using the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1121191